Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (3895)	12/18/1997 5:15:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

Business Overview VIVUS is a development stage company that researches advanced therapeutic systems for impotence, which affects an estimated 30% of males between the ages of 40 and 70. The company's Medicated Urethral System for Erection (MUSE) is a noninvasive, easy-to-use system that delivers topical pharmaceuticals via the urethra. The company's first product, MUSE-alprostadil, which is still in clinical trials, is a small, single-use disposable plastic applicator that dispenses a synthetic version of a naturally occurring hormone, prostaglandin, to achieve penile rigidity within 15 minutes of administration. The effect lasts approximately 30-60 minutes. as per market Guide, insiders own 33.94% <as of 12-5-97> institutions hold 65.32% 3 Lists, Insider BUYS, Insider sales, and Insider Form 144's: VVUS insider buys: NONE for year; any month. Insider sales: month $ amount #shares by who date avg price Jan NONE Feb NONE Mar 7,139,407 112,997 7-DDOOOCP 2-3 to 2-26 63.18 Apr NONE May 241,766 5,708 2-DP 4-15 to 4-18 42.36 June NONE July NONE Aug 4,116,015 136,833 6-DSDCPF 30.08 Sep NONE Oct 214,000 8,000 1-O 8-29 26.75 Nov 714,850 20,000 2-VF 10-13 35.74 Dec <to date> NONE Form 144's: Jan NONE Feb 2,715,790 53,160 5-ADAUU 51.09 Mar 2,868,509 39,837 6-DDAAAA 72.01 Apr 569,329 10,708 3-DFT 53.17 May NONE Jun 59,000 1,283 1-S 45.99 July 3,399,375 115,000 6-DDFDCP 29.56 Aug 1,509,021 51,833 2-DU 29.11 Sep 4,892,812 164,306 4-NDAS 29.78 Oct NONE Nov 250,000 10,000 1-A 25.00 Dec<to date> NONE